Bitter taste transduced by PLC-beta 2-dependent rise in IP3 and alpha -gustducin-dependent fall in cyclic nucleotides

Wentao Yan1, Gulshan Sunavala1, Sophia Rosenzweig1, Max Dasso1, Joseph G. Brand2,3, and Andrew I. Spielman1,2

1 Department of Basic Science and Craniofacial Biology, Division of Biological Science, Medicine, and Surgery, New York University College of Dentistry, New York, New York 10010; 2 Monell Chemical Senses Center, Philadelphia 19104-3308; and 3 Philadelphia Veterans Affairs Medical Center, and University of Pennsylvania, Philadelphia, Pennsylvania 19104


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Current evidence points to the existence of multiple processes for bitter taste transduction. Previous work demonstrated involvement of the polyphosphoinositide system and an alpha -gustducin (Galpha gust)-mediated stimulation of phosphodiesterase in bitter taste transduction. Additionally, a taste-enriched G protein gamma -subunit, Ggamma 13, colocalizes with Galpha gust and mediates the denatonium-stimulated production of inositol 1,4,5-trisphosphate (IP3). Using quench-flow techniques, we show here that the bitter stimuli, denatonium and strychnine, induce rapid (50-100 ms) and transient reductions in cAMP and cGMP and increases in IP3 in murine taste tissue. This decrease of cyclic nucleotides is inhibited by Galpha gust antibodies, whereas the increase in IP3 is not affected by antibodies to Galpha gust. IP3 production is inhibited by antibodies specific to phospholipase C-beta 2 (PLC-beta 2), a PLC isoform known to be activated by Gbeta gamma -subunits. Antibodies to PLC-beta 3 or to PLC-beta 4 were without effect. These data suggest a transduction mechanism for bitter taste involving the rapid and transient metabolism of dual second messenger systems, both mediated through a taste cell G protein, likely composed of Galpha gust/beta /gamma 13, with both systems being simultaneously activated in the same bitter-sensitive taste receptor cell.

taste transduction; denatonium; second messenger; rapid kinetics; taste receptors; inositol 1,4,5-trisphosphate; phospholipase C


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

CONTINUING PROGRESS IS BEING made toward understanding the biochemical and molecular biological mechanisms of cellular taste transduction (7, 14, 20, 23, 25, 45). Several properties of the peripheral taste process make studying this chemical sense intriguing. For example, taste sensations can be elicited by a variety of structurally diverse compounds, some of which do not show absolute specificity toward a given modality (i.e., sweet, bitter, salty, sour, umami). It is also becoming clear that the taste system uses a variety of transduction mechanisms to signal the presence of taste-active compounds. Among gustatory stimuli, those that trigger the modality of bitterness are most diverse in structure (6, 48). Of the natural compounds that taste bitter, many are essential in plant defense mechanisms, with some being toxic. Indeed, bitter taste can be considered as a warning and defensive modality, providing a final analytical detector just before ingestion. A variety of bitter-tasting mechanisms may have evolved in response to this structural diversity and potential toxicity (7, 12, 48).

During the past two decades, bitter taste mechanisms have been the focus of an increasing number of studies. These studies used several techniques, including psychophysics (4, 10, 27, 59), behavioral genetics (e.g., Refs. 26 and 56), neurophysiology (13, 21, 35, 36, 44, 49, 55, 58), calcium imaging (2, 37), biochemistry (17, 29, 31, 39, 41, 43, 47, 51), and molecular biology (1, 11, 15, 16, 28-30, 42, 43, 58). These diverse studies support the assumption that several receptor/transduction processes are involved in bitter taste.

Several of these studies point to the possible involvement of receptor-second messenger pathways in bitter taste transduction. In particular, there is strong evidence from calcium imaging, biochemical, and neurophysiological studies that the polyphosphoinositol pathway is involved in mediating bitterness (2, 16, 17, 33, 34, 36, 41, 42, 47, 50, 51). Still other work convincingly demonstrates that a gustatory tissue-enriched G protein, Galpha gust, mediates bitter taste transduction. Because of Galpha gust's sequence homology with the transducins, its activity is assumed to be via an activation of phosphodiesterases (PDE), thus implicating cyclic nucleotides as additional second messengers in bitter taste (21, 28, 29, 43, 45, 58).

We reasoned that both the polyphosphoinositol system and the cyclic nucleotide systems may be simultaneously activated in response to bitter compounds.

An important issue in supporting the relevance of several second messenger systems to bitter taste is measurement of the second messenger metabolism in real time. An outside limit to the initiation of a taste transduction response by most compounds can be set at ~250-500 ms after stimulus interaction with a receptor (19). Real-time assessment of biological processes in the millisecond time frame can be followed using stop-flow and quench-flow techniques. We and others have successfully developed and used these rapid kinetics procedures to measure second messenger metabolism in the millisecond time frame (8, 9, 16, 40-42, 51, 54).

Here we report second messenger metabolism in response to bitter stimuli in taste and control tissue from mouse SWR strain. Results indicate that bitter compounds such as denatonium and strychnine affect two second messenger systems simultaneously: they rapidly and reversibly elevate levels of inositol 1,4,5-trisphosphate (IP3) and suppress levels of cAMP and cGMP. The G protein subunits activated by these bitter stimuli and the enzymes that mediate the metabolism of these second messengers are delineated using antibodies specific to each component.


    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Tissue collection. Vallate and foliate taste papillae, along with control nongustatory lingual tissue, were collected from 6- to 8-wk-old SWR mice (Hilltop Lab Animals, Scottsdale, PA) by either carefully removing the papillae by a punch procedure (41, 46, 51) or peeling off the dorsal epithelium (5, 16). Peeling of the tissue was performed after subdermal injection of 4 mg/ml collagenase (type I; Boehringer Mannheim, Indianapolis, IN) and 1 mg/ml trypsin inhibitor (Worthington Biochemicals, Lakewood, NJ) in 50 mM MOPS buffer, pH 6.9, containing (in mM) 100 NaCl, 2.5 CaCl2, and 2.5 MgCl2 (MOPS I buffer). The tongue was incubated in this injection buffer for 20 min at 37°C, after which the entire posterior epithelium was peeled away under a dissecting microscope. From each peeled epithelium, one vallate and two foliate papillae and appropriate nongustatory control tissue were surgically isolated. Control tissue was removed from the dorsal eminence of the peeled epithelium, a region devoid of taste papillae. The tissue samples were washed in ice-cold MOPS II buffer [50 mM MOPS, pH 6.9, containing 100 mM NaCl, 2.5 mM MgCl2, 1 mM 1,4 dithiothreitol (DTT), 10 mM EGTA, and 81 µM CaCl2 to give a calculated free Ca2+ concentration of 0.010 µM] and a protease inhibitory cocktail [1 mg/ml, specific for serine, cysteine, aspartic and metallo-proteinases (Sigma, St. Louis, MO)]. In this study, tissue homogenates generated from the punch removal technique were used to collect data described in Figs. 1-4. Tissue homogenates generated from the epithelial peeling procedure were used for studies described by Figs. 5-7. Data from Figs. 1-4 were gathered early in this study. Subsequently (Figs. 5-7), we improved our tissue processing by removing some of the potential epithelial contaminants. This improvement also allowed us to use fewer mice per experiment. We checked to determine that the two preparations led to equivalent results.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 1.   Time course of denatonium benzoate (Dena, 10 mM)-induced inositol 1,4,5-trisphosphate (IP3) production in taste tissue from SWR mice (A) and in control nongustatory tissue (B). The x-axis represents the time (in ms) at which quenching of the mixture occurred. Data for the basal (no Dena added) levels (black-lozenge ) and Dena () are the means ± SE of 3 quadruplicate experiments. The Dena-stimulated elevation of IP3 in the gustatory tissue was significantly different from that of the basal level (buffer); *P < 0.0005.



View larger version (19K):
[in this window]
[in a new window]
 
Fig. 2.   Time course of strychnine (Stry, 10 mM)-induced IP3 production in taste tissue from SWR mice (A) and in control nongustatory tissue (B). The x-axis represents the time (in ms) at which quenching of the mixture occurred. Data for the basal levels (black-lozenge ) and strychnine () are the means ± SE of 3 quadruplicate experiments. The Stry-stimulated elevation of IP3 in the gustatory tissue was significantly different from that of the basal levels (buffer); *P < 0.05.



View larger version (17K):
[in this window]
[in a new window]
 
Fig. 3.   A: time course of suppression of prestimulated (PS) levels (black-lozenge ) of cGMP by the mixture of Dena and Stry (, 2 mM each). Data are the means ± SE of 3 experiments performed in triplicate. The suppression at 50, 75, and 100 ms was statistically significant (*P < 0.05) when compared with PS levels normalized to 100%. B: suppression of PS cAMP levels by Dena (2 mM) and Stry (2 mM). Data were collected at 50 ms and represent the mean of 3 triplicate experiments. Changes in cAMP levels due to Dena and/or Stry are statistically significant (*P < 0.001 for each value) compared with PS levels.



View larger version (21K):
[in this window]
[in a new window]
 
Fig. 4.   A: the effect of antibodies to the taste-enriched G protein alpha -gustducin (Galpha gust) on Dena (D)-mediated drop in cAMP measured at 50 ms after stimulation by Dena in taste tissue homogenates. PS cAMP levels were reduced by 1 mM Dena (*P < 0.001). Suppression of cAMP was not affected by normal IgG (D+nIgG, 10 µg; P < 0.001 compared with PS) but was restored in the presence of antibodies to Galpha gust (D+AntiG, 10 µg; P < 0.001 compared with Dena and D+nIgG). Data represent the means ± SE of 9-16 data points. B: the effect of AntiG on Dena-mediated drops in cGMP at 50 ms after stimulation by Dena in taste tissue homogenates. PS cGMP levels were reduced by 1 mM Dena (*P < 0.05). Suppression of cGMP was not affected by nIgG (D+nIgG, 10 µg; **P < 0.01 compared with PS) but was restored in the presence of AntiG (D+AntiG, 10 µg; ***P < 0.001 compared with Dena and D+nIgG). Data represent the means ± SE of 23-25 data points.



View larger version (18K):
[in this window]
[in a new window]
 
Fig. 5.   A: the effect of AntiG on Stry (S)-mediated drop in cAMP measured at 50 ms after stimulation by Stry in taste tissue homogenates. PS cAMP levels were reduced by 2 mM Stry (*P < 0.005). Suppression of cAMP was affected neither by nIgG (S+nIgG, 10 µg) nor AntiG (D+AntiG). Data represent the means ± SE of 24 data points. B: the effect of AntiG on Stry-mediated drop in cGMP at 50 ms after stimulation by Stry in taste tissue homogenates. PS cGMP levels were reduced by 2 mM Stry (**P < 0.005). Suppression of cGMP was not affected by nIgG (S+nIgG, 10 µg; *P < 0.001 compared with PS) but was restored in the presence of AntiG (10 µg, P < 0.005 compared with Stry and S+nIgG). Data represent the means ± SE of 22-24 data points.



View larger version (15K):
[in this window]
[in a new window]
 
Fig. 6.   A: the effect of AntiG on Dena-mediated increases in IP3 at 50 ms after Dena (1 mM) stimulation of taste tissue homogenates. The elevation of IP3 (Dena) was unaffected by either nIgG (D+nIgG) or AntiG (D+AntiG). B: the effect of AntiG on Stry-mediated increases in IP3 at 50 ms after Stry (2 mM) stimulation of taste tissue homogenates. The elevation of IP3 (Stry) was unaffected by either nIgG (S+nIgG) or AntiG (S+AntiG). Bsl, basal cyclic nucleotide level.



View larger version (22K):
[in this window]
[in a new window]
 
Fig. 7.   A: the effect of antibodies to different phospholipase C (PLC) subtypes on Dena-mediated IP3 increase. At 50 ms, the Dena (1 mM) induced IP3 increase (Dena) was inhibited by antibodies to PLC-beta 2 (D+Anti-Beta2, P < 0.05), although this increase was not affected by antibodies to either PLC-beta 3 or PLC-beta 4 (D+Anti-Beta3, D+Anti-Beta4). The inhibition by Anti-Beta2 was blocked by the blocking peptide for the antibodies (D+BP+Anti-Beta2, *P < 0.05). B: the effect of Anti-Beta2 on cyclic nucleotide levels. At 50 ms, PS levels of cAMP or cGMP were not affected by PLC-beta 2 antibodies (Anti-PLC) in the presence or absence of the specific blocking peptide (BP). NS, not significant. Data represent the means of 3-12 data points ± SE.

For a typical experiment, taste and control tissue from 25-30 mice were homogenized using a glass-glass homogenizer in MOPS III buffer (equivalent to MOPS II buffer without enzyme inhibitors). The homogenate was centrifuged at 2,000 g for 10 min at 4°C. The supernatant (diluted to an appropriate protein concentration) was retained. Free calcium levels were calculated using the Chelator software (shareware, Dr. T. J. M. Schoenmakers, Dept. of Animal Physiology, Toernooiveld, Nijmegen 6525, The Netherlands). Protein analysis followed the Bradford assay using bovine gamma globulin as a standard (Bio-Rad, Hercules, CA).

Chemicals. Denatonium benzoate, strychnine HCl, and caffeine were purchased from Sigma. Rabbit polyclonal IgG antibodies to Galpha gust (IgG), to phospholipase C-beta 2 (PLC-beta 2), PLC-beta 3, and PLC-beta 4 (and their respective blocking peptides), and normal (control) rabbit IgG (nIgG) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). [3H]IP3 and kits for assaying cyclic nucleotides (cAMP and cGMP) and IP3 were purchased from NEN (Boston, MA). All other chemicals were of the highest purity available and were purchased from either Sigma or Calbiochem (San Diego, CA).

Quench-flow rapid kinetics. A quench-flow module (QFM5, BioLogic; Molecular Kinetics, Pullman, WA) equipped with five syringes was used to measure the subsecond kinetics of second messenger formation. (For description and operation details, see Refs. 41, 51, 54). In our QFM5 system, the first syringe was filled with MOPS III buffer supplemented with freshly prepared 1 mM ATP, 1 µM GTP, and 0.05% sodium cholate (hereafter called basal buffer). Bitter stimulants or pharmacological agents were dissolved into this basal buffer. The following stimulants and concentrations were tested (in mM): 2 and 10 strychnine and 1, 2, and 10 denatonium. For measures of cyclic nucleotides, the PDE inhibitor caffeine (25 mM) was added to the stimulus and control buffers for both taste and control tissues to raise the basal levels of the cyclic nucleotides (41).

The second syringe contained taste tissue or control homogenate in MOPS III buffer at a concentration of 35-50 µg/ml, except for studies shown in Figs. 5-7, where the protein concentration was 85-100 µg/ml. Tissue was maintained at 4°C at all times and loaded into the second syringe in small batches just seconds before injection at 22°C. The third syringe contained 9% perchloric acid to quench the reactions.

The reaction was initiated by mixing 60 µl basal buffer or basal buffer containing stimulants with 60 µl tissue. After 0, 25, 50, 100, 200, and 500 ms, the reaction was terminated by injection of 60 µl of 9% perchloric acid. For each time point this was repeated twice, so the collected volume for each time point was 360 µl. The activation of all syringes was controlled by a personal computer, using a software developed by the manufacturer (BioLogic) and drive sequences developed in our laboratory. For the zero time point, tissue was first quenched with ice-cold perchloric acid and then stimulated.

When antibodies to Galpha gust or to the PLC-beta s (10 µg/ml antibody per 35-100 µg protein/ml) or nIgG (same concentration) were used, the homogenate was preincubated with the antibodies for 90 min at 4°C and subsequently exposed to a particular buffer or stimulant. When blocking peptides were used, each blocking peptide was incubated with its appropriate antibody at 4°C overnight, and then the peptide-treated antibodies were incubated with the tissue under the conditions indicated above for antibodies not pretreated with blocking peptides. For studies involving blocking peptides alone, the same procedure was followed, except no antibody was added. After quenching, 330 µl (out of a total 360 µl) of the product was stored at -20°C until assayed.

Extraction and assay of cAMP and cGMP. On the day of the assay, samples were thawed and centrifuged at 1,000 g for 5 min. Cyclic nucleotides and IP3 (shown in Figs. 6 and 7) were extracted from the supernatant by mixing with 82.5 µl of 10 mM EDTA, pH 7.0, and 10 µl of Universal Indicator, with pH adjusted further to pH 7.0 using 1.5M KOH and 60 mM HEPES (38). The mix was centrifuged at 1,200 g for 5 min at 4°C. The supernatant was assayed either for cGMP and cAMP (using a 125I-labeled RIA kit from NEN) or for IP3 (see below).

Extraction and assay of IP3. Each sample was centrifuged at 1,000 g for 5 min, and the supernatant was mixed 5:1 with 10 mM Tris-EDTA, pH 9.0 (vol/vol), and further mixed with an equal volume of a freshly prepared mixture of 1:1 freon: tri-n-octylamine. Samples were vortex-mixed for 15 s and spun at 2,000 g for 1 min at 25°C. The upper phase (400 µl) was assayed for IP3.

IP3 was assayed using either a commercially available kit (NEN) or an IP3-binding protein extracted from bovine adrenal gland. For studies using the adrenal extract, an 3H-labeled IP3 tracer was used. Extraction of this binding protein followed the protocol described by Palmer and Wakelam (38). Because the binding protein is contained within a partial membrane preparation of the adrenal cortex, a differential centrifugation procedure was employed. Briefly, bovine adrenal cortex was dissected from six glands at a time and homogenized in 200 mM NaHCO3 and 1 mM DTT at 4°C. The homogenate was centrifuged at 5,000 g for 15 min. The supernatant was diluted to 40 ml with the NaHCO3 homogenization buffer and spun at 35,000 g for 20 min. The pellet was resuspended in 40 ml NaHCO3 buffer and centrifuged twice more. The final pellet from the final spin was resuspended in 12 ml of buffer at a protein concentration of 20-40 mg/ml. The binding protein was aliquoted at 30 mg/tube and frozen at -80°C until used. Each tube containing binding protein was thawed only once.

All steps for the IP3 assay were performed in siliconized tubes. The assay followed a published procedure (38) with minor modifications. The assay volume was half of that described (38) to conserve binding protein. Centrifugation of the final pellet was increased to 12,000 g for 4 min to improve reproducibility between duplicates.

Data analyses. Data analyses were performed by comparing the areas under the time/concentration curves between the basal and stimulated levels (0-200 or 0-500 ms) of IP3 anabolism or cyclic nucleotide catabolism. Six to eighteen measurements per point were made. Variation among triplicates was usually between 1 and 7% but not greater than 10%. It was possible to calculate the residual random error of the basal and stimulated regions. Two-sample (nonpaired) Student's t-tests were employed with statistical significance designated at the 95% level (alpha  = 0.05). The actual P values are reported in the figure legends.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Bitter stimulus-induced metabolism of second messengers. Stimulation of the mouse gustatory tissue with 1, 2, and 10 mM denatonium resulted in a rapid and transient increase in IP3 production. Figure 1A shows that for 10 mM denatonium, levels of IP3 were increased by the first time point measured, 25 ms, and peaked at 75-100 ms. These levels then declined, returning close to basal levels after 200 ms. IP3 levels in gustatory tissue not stimulated by denatonium remained unchanged. When the same experiment using 10 mM denatonium was performed with nongustatory control tissue, IP3 levels were not significantly affected (Fig. 1B).

Likewise, 2 or 10 mM strychnine HCl rapidly induced elevated levels of IP3, which peaked at 100 ms. However, unlike the IP3 levels seen for denatonium, those for strychnine showed a slower return to basal levels (Fig. 2A, using 10 mM strychnine). The peak IP3 levels doubled compared with basal IP3 production when 10 mM strychnine was the stimulus. IP3 levels of gustatory tissue not stimulated by strychnine did not fluctuate. With nongustatory control tissue, 10 mM strychnine induced an IP3 increase that was about half of that seen in the gustatory tissue (Fig. 2B). From 50 to 100 ms, this increase was significantly different from the basal unstimulated controls.

On the other hand, the effect of strychnine and/or denatonium on cyclic nucleotide levels demonstrated the opposite effect. When gustatory tissue was stimulated by strychnine and/or denatonium, cyclic nucleotide levels were suppressed from 0 to 100 ms. Figure 3A shows the time course of the relative levels of cGMP when gustatory tissue was stimulated by a mixture of 2 mM denatonium and 2 mM strychnine. This mixture of denatonium and strychnine decreased cGMP levels to 54% of the prestimulated (caffeine alone) levels, with a maximum effect noticeable at about 50 ms (Fig. 3A). The time course for denatonium plus strychnine-induced changes in the level of cAMP (data not shown) was similar to that seen for cGMP.

Figure 3B shows bitter-induced changes in cAMP levels at the 50-ms time point only. By 50 ms, denatonium alone at 2 mM suppressed cAMP levels to 55% of their prestimulated (caffeine only) value, whereas strychnine alone at 2 mM reduced this level to 40%. In Fig. 3B, as in Figs. 4 and 5, the zero value refers to the basal level of cyclic nucleotide in the homogenate before either caffeine and/or denatonium or strychnine addition. The 100% level is the normalized amount of cyclic nucleotide available after caffeine (alone) inhibition of the PDEs.

Role of Galpha gust in bitter-stimulated second messenger metabolism. To understand the mechanism of cyclic nucleotide catabolism and IP3 anabolism in taste tissue, we tested the possible role of Galpha gust in generating these rapid changes in second messenger levels. Because specific antibodies to Galpha gust exist, we preincubated taste and control tissues with antibodies to Galpha gust or with a preimmune IgG fraction (see MATERIALS AND METHODS) in an attempt to rescue the bitter stimulus-mediated metabolism of cGMP, cAMP, and IP3.

The results demonstrate that antibodies to Galpha gust, but not preimmune IgG, blocked the denatonium (1 mM)-induced suppression cyclic nucleotide levels to their prestimulated (i.e., caffeine stimulated) levels (Fig. 4, A and B). Figure 4A demonstrates that, at the 50-ms time point, denatonium suppresses cAMP levels (as shown also in Fig. 3) but that this decrease was blocked by preincubation of the tissue with an antibody to Galpha gust. The decrease was not blocked, however, by preincubating the taste tissue with preimmune IgG. The same pattern is seen when cGMP is measured (Fig. 4B). Nongustatory tissue did not demonstrate suppression of cAMP or cGMP by denatonium, and there was no effect of the Galpha gust antibodies nor of preimmune IgG on the levels of these messengers after denatonium stimulation (data not shown).

Similar to denatonium, 2 mM strychnine suppressed levels of cAMP (Figs. 3B and 5A) and cGMP (Fig. 5B). In the case of strychnine, however, the suppression of cAMP was not rescued by the Galpha gust antibodies (Fig. 5A), whereas the strychnine suppression of cGMP was rescued by the Galpha gust antibodies (Fig. 5B).

Data shown in Fig. 6 demonstrate that antibodies to Galpha gust had no effect on the denatonium- (Fig. 6A) or strychnine (Fig. 6B)-induced increases in IP3. Measurements made at the 50-ms time point show that these bitter-induced increases in IP3 remained unchanged after the tissue was preincubated either with preimmune IgG or with antibodies specific to Galpha gust.

Role of PLC-beta 2 in bitter stimulus-induced production of IP3. Generation of IP3 and diacylglycerol (DAG) is the result of the action of the enzyme PLC on the minor membrane lipid phosphatidylinositol 4,5-bisphosphate. There are several types of PLCs defined by their sensitivities to modulatory compounds and by their structural attributes (18, 42, 57). Antibodies to PLC-beta 2, PLC-beta 3, and to PLC-beta 4 were used to determine if one or more of these inhibited the denatonium-induced rise in IP3 levels in taste homogenates. Figure 7 shows data at the 50-ms time point for denatonium-induced changes in IP3 levels in the absence of any antibodies or blocking peptides and in the presence of denatonium plus antibodies to PLC-beta 2, PLC-beta 3, and PLC-beta 4. The data show that only in the presence of antibodies to PLC-beta 2 was the denatonium-induced rise in IP3 levels inhibited. This inhibition could be blocked when antibody to PLC-beta 2 was preincubated with its blocking peptide. Blocking peptide-pretreated antibodies to PLC-beta 3 and PLC-beta 4 and blocking peptide alone did not affect denatonium-induced IP3 increase. In addition, antibodies to PLC-beta 2 did not affect cAMP or cGMP levels (Fig. 7B).


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Because of the diverse chemical structures of substances that taste bitter, it has long been assumed that there are multiple receptor mechanisms for the modality of bitterness. The literature generally supports this suggestion (for reviews, see Refs. 7 and 48). For example, there is both direct and inferential evidence that bitterness may be transduced by direct interaction of bitter compounds with biophysical properties of the membrane (e.g., Refs. 23 and 32), by interaction with intracellular components, bypassing a receptor step (31, 39, 41, 48), by direct modulation of stimulus-gated plasma membrane ion channels (48, 49, 55), and by more traditional G protein-coupled receptor (GPCR) processes (1, 11). One such receptor/transduction mechanism using the GPCR route is one that leads to the metabolism of second messengers (for reviews, see Refs. 7, 20, 24, 25, 45). Our previous work suggests that both the polyphosphoinositides and/or the cyclic nucleotides act as second messengers in bitter taste GPCR transduction (41, 47, 51).

The involvement of IP3 as a possible second messenger for bitter taste signal transduction has received support from several studies (2, 16, 17, 33, 34, 36, 41, 42, 47, 51). For example, we previously demonstrated that taste tissue homogenates from mice show a rapid and transient bitter stimulus-induced production in the second messenger IP3 (51). This increase occurs within the physiologically relevant first 200 ms, making it likely that IP3 could act as a second messenger in bitter taste. The finding that the gustatory-enriched G protein Galpha gust (28) was involved in bitter taste transduction (58) and that this G protein showed high sequence homology with the transducins suggested that taste PDE (43), acting on cyclic nucleotide levels, may also be a messenger system for bitter taste (45). Our new findings, described in this current work, support the suggestion that some bitter-tasting compounds may simultaneously alter second messenger levels of both the polyphosphoinositol system and the cyclic nucleotide systems in a G protein-dependent manner.

Second messenger metabolism in the millisecond time frame. The data presented here confirm that denatonium and strychnine can rapidly and transiently increase IP3 levels in taste tissue from mice. Data shown in Figs. 1 and 2 demonstrate that IP3 is increased after tissue stimulation by both denatonium and strychnine. Both of these responses were tissue specific, being significant at the P < 0.005 level. The data show rising IP3 levels from the first point of measurement, 25 ms, to 100 ms, after which the values for IP3 begin to decline rapidly for denatonium, but less rapidly for strychnine. Some increases in IP3 levels are seen with nongustatory controls, although the magnitude of these is much less than that seen with gustatory tissues. Such activity in nongustatory tissue for some bitter compounds has been noted previously (33, 51) and is likely due to the fact that many bitter stimuli are pharmacologically active.

Data from this study plus those from previous ones (50, 51) show that rapid increases in IP3 levels in rodent taste tissue are detected for the bitter-tasting stimuli, denatonium, strychnine, sucrose octaacetate, caffeine, quinine, naringin, and benzyltriethylammonium chloride (50, 51, 52, 53).

In addition to the bitter taste-induced changes in IP3 levels, we show here, for the first time, that these same bitter stimuli can significantly reduce levels of both cAMP and cGMP within the millisecond time frame (Figs. 3-5). Data of Fig. 3A show that cGMP levels reach their minimum values by 50 ms, returning thereafter to near baseline levels by 150 ms. The decrease in nucleotide levels is likely due to the stimulation of a PDE by Galpha gust (see below). The rapid increase in cyclic nucleotide levels after 50 ms may be due to the activation of several systems including a gradual decline in PDE activity and/or by a parallel increase in cyclic nucleotide synthesis. The data presented here cannot be used to distinguish between these possibilities, and further work is required to resolve this question.

One of the major hypotheses on bitter taste transduction states that bitter stimuli induce a receptor-mediated activation of a PDE through the action of the taste G protein, Galpha gust. If this were the case, then one would expect to observe a decrease in cyclic nucleotides due to stimulation by bitter compounds. Initial attempts to show such decreases using homogenates were only suggestive (34, 53). Only minimal lowering of cyclic nucleotides was seen, likely because the initial levels of cyclic nucleotides in the homogenate were very low, due to the very active PDEs. On the basis of our previous experimental work in taste, we knew that potent PDEs are present in these tissues, and that methyl xanthines were able to inhibit these, but only at high levels.

At the suggestion of a colleague (Dr. Heinz Breer, Stuttgart, Germany) we adopted the common procedure of adding a xanthine inhibitor of PDE [caffeine (41)] to raise the levels of cyclic nucleotides in our homogenate preparation. We chose to use 25 mM caffeine in these studies because at this concentration, consistently high and readily assayed concentrations of cyclic nucleotides could be sustained, allowing us to at least approach the testing of the hypothesis outlined above. Although 25 mM is a high level, it is not so high as to block the bitter stimulus-induced, Galpha gust-mediated activation of PDE to affect a rapid, and even reversible, drop in cyclic nucleotides. Although we cannot rule out the possibility that caffeine may affect other systems in the homogenate, the fact that a taste-specific, Galpha gust-mediated drop in cyclic nucleotides is seen in gustatory and not in control (nongustatory) tissue makes the use of this compound justified for this initial test of the gustducin hypothesis.

Just what the conditions are within the cell that might permit Galpha gust signaling to effect a drop in cyclic nucleotides is unknown. But, unlike the homogenate, which, when being produced, likely quickly depletes cyclic nucleotides because no synthesis is occurring, in the cell, both synthesis and normal PDE-mediated degradation of cyclic nucleotides are at a steady state. Upon taste stimulation, the action of Galpha gust further stimulates PDE to effect a transient drop in cyclic nucleotides. Our homogenate cannot accurately mimic these dynamic events. In the face of depleted cyclic nucleotides, we need to not only allow some synthesis to occur (by adding ATP at time 0) but also partially inhibit PDE to measure the drop in nucleotides.

Adding caffeine simultaneously with either denatonium or strychnine resulted in a taste tissue-specific decrease in cyclic nucleotide levels. In contrast to the ability of denatonium and strychnine to lower cyclic nucleotide levels in taste tissue, caffeine and other xanthines raise levels of cyclic nucleotides, suggesting an alternate mechanism for bitter taste transduction for these bitter tasting and membrane-permeable PDE inhibitors (e.g., Refs. 22 and 41).

We estimated the stimulus thresholds for both the IP3 increases and the cyclic nucleotide decreases, for both denatonium and strychnine, to be in the range of 0.1 to 0.5 mM. These values are consistent with, though somewhat higher than, behavioral avoidance thresholds reported by Whitney et al. (56). The observation of slightly higher threshold values from the in vitro work presented here is not surprising given the likely weaker coupling of the major transduction constituents in the homogenate compared with their coupling in vivo.

G protein-mediated second messenger responses. Data in Figs. 4 and 5 demonstrate that the denatonium- and strychnine-induced decreases in cyclic nucleotides are dependent upon Galpha gust. When antibodies to Galpha gust were preincubated with the taste homogenate, neither denatonium nor strychnine was able to induce a reduction in the levels of either cAMP or cGMP. Antibodies from nonimmune serum were ineffective. This block by antibodies to Galpha gust in taste tissue homogenates was not seen with homogenates from nontaste tissue controls. The failure of the Galpha gust antibodies to rescue the strychnine-induced decreases in cAMP (Fig. 5) may imply additional control elements for transducing signals from this and other bitter compounds.

In contrast, antibodies to Galpha gust were ineffective at altering the denatonium- and strychnine-induced increases in IP3 of taste homogenates (Fig. 6). These data, therefore, suggest that bitter stimuli alter levels of cyclic nucleotides by a Galpha gust activation of a taste PDE but that stimulation of a PLC is Galpha gust independent.

A recent study demonstrated that the bitter-induced increase in IP3 levels was dependent upon the beta /gamma -subunit of a G protein (16). Antibodies to a taste Ggamma 13-subunit prevented the denatonium-stimulated rapid production of IP3. This observation and the data of Rossler et al. (42) from rat taste tissue suggest that the PLC type responsible for taste-induced production of IP3 is a PLC-beta -type phospholipase. When antibodies to the PLC-beta types 2, 3, and 4 were preincubated with taste tissue homogenates, only the antibodies to the PLC-beta 2 subtype inhibited the denatonium-induced increase in IP3. Use of blocking peptides confirmed that this effect was specific to the antibodies to PLC-beta 2 (Fig. 7).

Bitter taste transduction mechanisms. From the new data presented here and from results of previous work, one can hypothesize that bitter taste signal transduction for denatonium and strychnine involve both a Galpha gust-dependent, PDE-mediated reduction in cyclic nucleotide levels and a Ggamma 13-dependent, PLC-beta 2-mediated increase in IP3. Both of these changes in second messenger metabolism occur within 100 ms, a time frame consistent with taste transduction. The data of Huang et al. (16) show that a taste cell-enriched Ggamma 13-subunit and the Galpha gust-subunit colocalize to the same cells, making it likely that the heterotrimeric G protein involved in bitter taste is composed of Galpha gust and Gbeta gamma 13. In addition, the recently identified bitter taste receptors were found to colocalize with Galpha gust (1).

These data lead to a comprehensive model of one mechanism for bitter taste transduction (Fig. 8). In this construct, the bitter stimuli interact with 7TM receptors, most likely those recently identified (1, 11). According to Chandrashekar et al. (11), it is very likely that the receptor for denatonium is molecularly distinct from that for strychnine. [This receptor step may not always be sufficient or necessary for initiating or sustaining the bitter taste response, because hydrophobic taste stimuli can cross the taste cell plasma membrane and possibly interact directly with intracellular targets (31, 39, 48)]. The binding of the bitter stimulus with its receptor(s) then activates the taste cell G protein, in this case, perhaps, Galpha gust/Gbeta gamma 13. The Galpha gust activates one or more type of PDE, resulting in the breakdown of cyclic nucleotides within a time frame of 50-75 ms. This transitory nature of the cyclic nucleotide response may possibly be due to an adaptation mechanism such as phosphorylation of the cell-surface receptor(s), inactivation of Galpha gust, and/or stimulation of cyclic nucleotide synthesis, mechanisms that cannot be discerned from the current data. Simultaneously, the Gbeta gamma 13 activates a PLC-beta 2, resulting in the production of the two second messengers, DAG and IP3, within a time frame of 50-100 ms. The exact targets of these second messengers are not known. The cyclic nucleotides may, for example, stimulate the activity of a cyclic nucleotide-inhibitable ion channel (21) or a cyclic nucleotide-stimulated ion channel (30), altering cellular conductance. The messengers IP3 and DAG may act to release calcium from intracellular stores and activate protein kinases, respectively. There is also evidence for a cyclic nucleotide-stimulated activation of a protein kinase in taste cells (3). The observation that the metabolism of these different second messenger pathways is stimulated by components of the same heterotrimeric G protein, i.e., Galpha gust/Gbeta gamma 13, leads us to hypothesize that the bitter stimulus-induced reductions in cyclic nucleotides and the bitter stimulus-induced increases in IP3 occur within the same bitter sensitive cell.


View larger version (55K):
[in this window]
[in a new window]
 
Fig. 8.   Hypothesized G protein-coupled receptor model of Dena and Stry signal transduction in taste tissue. Dena and Stry bind to specific taste receptors. These receptors activate the taste-enriched G protein, gustducin. The activated G protein splits into the Galpha gust-subunit and a beta gamma 13-subunit. The Galpha gust activates phosphodiesterases (PDEs) and enhances their ability to degrade cAMP and cGMP. Variation in cyclic nucleotide levels is rapid and transitory possibly due to an adaptation mechanism such as receptor or Galpha gust inactivation, PDE reactivation, or stimulation of cyclic nucleotide synthesis. This decrease in cyclic nucleotide may open cyclic nucleotide suppressible cation channels, which normally bind cyclic nucleotides and remain closed during the resting state. The opening of these channels affects cellular conductance and depolarizes taste receptor cells. Concurrent with the changes in cyclic nucleotide levels, the beta gamma -subunit activates a taste-specific PLC-beta 13, converting phosphatidylinositol 4,5-bisphosphate into diacylglycerol (DAG) and IP3. The increase in IP3 releases calcium from intracellular stores and further depolarizes the cell.


    ACKNOWLEDGEMENTS

The authors acknowledge the excellent technical assistance of D. Bayley, P. Iskander, D. Chen, and F. LeGeros.


    FOOTNOTES

This study was supported by National Institute of Dental Research Grant DE-10754, the United States-Israel Binational Agricultural Research and Development Fund (IS 2518), and Procter & Gamble (to A. I. Spielman), and the Department of Veterans Affairs and National Institute on Deafness and Other Communication Disorders Grants DC-00356 and DC-03969 (to J. G. Brand.)

Present address for G. Sunavala: Dept. of Biochemistry and Molecular Biology, Louisiana State Univ., Shreveport, LA 71130.

Address for reprint requests: A. I. Spielman, Div. of Biological Science, Medicine, and Surgery, New York Univ. College of Dentistry, 345 E. 24th St., New York, NY 10010. E-mail correpondence to: andrew.spielman{at}nyu.edu or joe.brand{at}monell.org.

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received 13 April 2000; accepted in final form 20 October 2000.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Adler, E, Hoon MA, Mueller KL, Chandrashekar J, Ryba NJP, and Zuker CS. A novel family of mammalian taste receptors. Cell 100: 693-702, 2000[ISI][Medline].

2.   Akabas, MH, Dodd J, and Al-Awqati Q. A bitter substance induces a rise in intracellular calcium in a subpopulation of rat taste cells. Science 242: 1047-1050, 1988[ISI][Medline].

3.   Avenet, P, Hofmann F, and Lindemann B. Transduction in taste receptor cells requires cAMP-dependent protein kinase. Nature 331: 51-54, 1988.

4.   Barnicot, NA, Harris H, and Kalmus H. Taste thresholds of further eighteen compounds and their correlation with PTC thresholds. Ann Eugen Lond 16: 119-128, 1951.

5.   Behe, P, DeSimone JA, Avenet P, and Lindemann B. Membrane currents in taste cells of the rat fungiform papilla: evidence for two types of Ca2+ currents and inhibition of K+ currents by saccharin. J Gen Physiol 96: 1061-1084, 1990[Abstract].

6.   Belitz, HD, and Wieser H. Bitter compounds: occurrence and structure-activity relationships. Food Rev Int 1: 271-354, 1985.

7.   Brand, JG. Biophysics of taste. In: Tasting and Smelling, edited by Beauchamp GK, and Bartoshuk L.. San Diego: Academic, 1995, p. 1-24.

8.   Breer, H, and Boekhoff I. Odorants of the same odor class activate different second messenger pathways. Chem Senses 16: 19-29, 1991[ISI].

9.   Breer, H, Boekhoff I, and Tareilus E. Rapid kinetics of second messenger formation in olfactory transduction. Nature 345: 65-68, 1990[ISI][Medline].

10.   Breslin, PA, and Beauchamp GK. Suppression of bitterness by sodium: variation among bitter taste stimuli. Chem Senses 20: 609-623, 1995[Abstract].

11.   Chandrashekar, J, Mueller KL, Hoon MA, Adler E, Feng L, Guo W, Zuker CS, and Ryba NJP T2Rs function as bitter taste receptors. Cell 100: 703-711, 2000[ISI][Medline].

12.   Glendinning, JI. Is the bitter rejection response always adaptive? Physiol Behav 56: 1217-1227, 1994[ISI][Medline].

13.   Glendinning, JI, and Hills TT. Electrophysiological evidence for two transduction pathways within a bitter-sensitive taste receptor. J Neurophysiol 78: 734-745, 1997[Abstract/Free Full Text].

14.   Herness, MS, and Gilbertson TA. Cellular mechanisms of taste transduction. Annu Rev Physiol 61: 873-900, 1999[ISI][Medline].

15.   Hoon, MA, Adler E, Lindemeier J, Battey JF, Ryba NJP, and Zuker CS. Putative mammalian taste receptors: a class of taste-specific GPCRs with distinct topographic selectivity. Cell 96: 541-551, 1999[ISI][Medline].

16.   Huang, L, Shanker YG, Dubauskaite J, Zheng JZ, Yan W, Rosenzweig S, Spielman AI, Max M, and Margolskee RF. Ggamma 13 colocalizes with gustducin in taste receptor cells and mediates IP3 responses to bitter denatonium. Nat Neurosci 2: 1055-1062, 1999[ISI][Medline].

17.   Hwang, PM, Verma A, Bredt DS, and Snyder SH. Localization of phosphatidylinositol signaling components in rat taste cells: role in bitter taste transduction. Proc Natl Acad Sci USA 87: 7395-7399, 1990[Abstract].

18.   Katan, M. Families of phosphoinositide-specific phospholipase C: structure and function. Biochim Biophys Acta 1436: 5-17, 1998[ISI][Medline].

19.   Kelling, ST, and Halpern BP. Gustatory neural response latencies in the frog. Chem Senses 18: 169-187, 1993[ISI].

20.   Kinnamon, SC, and Margolskee RF. Mechanisms of taste transduction. Curr Opin Neurobiol 6: 506-513, 1996[ISI][Medline].

21.   Kolesnikov, SS, and Margolskee RF. A cyclic-nucleotide-suppressible conductance activated by transducin in taste cells. Nature 376: 85-88, 1995[ISI][Medline].

22.   Kurihara, K. Inhibition of cyclic 3',5'-nucleotide phosphodiesterase in bovine taste papillae by bitter taste stimuli. FEBS Lett 27: 279-281, 1972[ISI][Medline].

23.   Kurihara, K. Molecular mechanisms of reception and transduction in olfaction and taste. Jpn J Physiol 40: 305-324, 1990[ISI][Medline].

24.   Lindemann, B. Taste reception. Physiol Rev 76: 719-766, 1996[ISI].

25.   Lindemann, B. Receptor seeks ligand: on the way to cloning the molecular receptors for sweet and bitter taste. Nat Med 5: 381-382, 1999[ISI][Medline].

26.   Lush, IE. The genetics of bitterness, sweetness and saltiness in strains of mice. In: Genetics of Perception and Communication, , edited by Wysocki C, and Kare MR.. New York: Marcel Dekker, 1991, p. 227-241.

27.   McBurney, DH, Smith DV, and Shick TR. Gustatory cross adaptation: sourness and bitterness. Percept Psychophys 11: 228-232, 1972[ISI].

28.   McLaughlin, SK, McKinnon PJ, and Margolskee RF. Gustducin is a taste-cell-specific G-protein closely related to the transducins. Nature 357: 563-569, 1992[ISI][Medline].

29.   Ming, D, Avila RL, and Margolskee RF. Characterization and solubilization of bitter-responsive receptors that couple to gustducin. Proc Natl Acad Sci USA 95: 8933-8938, 1998[Abstract/Free Full Text].

30.   Misaka, T, Kusakabe Y, Emori Y, Gonoi T, Arai S, and Abe K. Taste buds have a cyclic-nucleotide-activated channel, CNGgust. J Biol Chem 272: 22623-22629, 1997[Abstract/Free Full Text].

31.   Naim, M, Seifert R, Nurnberg B, Grünbaum L, and Schultz G. Some taste substances are direct activators of G-proteins. Biochem J 297: 451-454, 1994[ISI][Medline].

32.   Naito, M, Sasaki N, and Kambara T. Mechanism of the electric responses of lipid bilayers to bitter substances. Biophys J 65: 1219-1232, 1993[Abstract].

33.   Nakashima, K, and Ninomiya Y. Increase in inositol 1,4,5-trisphosphate levels of the fungiform papilla in response to saccharin and bitter substances in mice. Cell Physiol Biochem 8: 224-230, 1998[ISI][Medline].

34.   Nakashima, K, and Ninomiya Y. Transduction for sweet taste of saccharin may involve both inositol 1,4,5-trisphosphate and cAMP pathways in the fungiform taste buds in C57BL mice. Cell Physiol Biochem 9: 90-98, 1999[ISI][Medline].

35.   Ogura, T, and Kinnamon SC. IP(3)-independent release of Ca(2+) from intracellular stores: a novel mechanism for transduction of bitter stimuli. J Neurophysiol 82: 2657-2666, 1999[Abstract/Free Full Text].

36.   Ogura, T, Mackay-Sim A, and Kinnamon SC. Bitter taste transduction of denatonium in the mudpuppy Necturus maculosus. J Neurosci 17: 3580-3587, 1997[Abstract/Free Full Text].

37.   Orola, CN, Yamashita T, Harada N, Amano H, Ohtani M, and Kumazawa T. Intracellular free calcium concentrations in single cell taste receptor cells in guinea pig. Acta Otolaryngol (Stockh) 112: 120-127, 1992[ISI][Medline].

38.   Palmer, S, and Wakelam MJO Mass measurement of inositol 1,4,5-trisphosphate using a specific binding assay. In: Methods in Inositide Research, edited by Irvine RF.. New York: Raven, 1990, p. 127-134.

39.   Peri, I, Mamrud-Brains H, Rodin S, Krizhanovsky V, Shai Y, Nir S, and Naim M. Rapid entry of bitter and sweet tastants into liposomes and taste cells: implications for signal transduction. Am J Physiol Cell Physiol 278: C17-C25, 2000[Abstract/Free Full Text].

40.   Restrepo, D, Boekhoff I, and Breer H. Rapid kinetic measurements of second messenger formation in olfactory cilia from channel catfish. Am J Physiol Cell Physiol 264: C906-C911, 1993[Abstract/Free Full Text].

41.   Rosenzweig, S, Yan W, Dasso M, and Spielman AI. Possible novel mechanism for bitter taste mediated through cGMP. J Neurophysiol 81: 1661-1665, 1999[Abstract/Free Full Text].

42.   Rossler, P, Kroner C, Freitag J, Noe J, and Breer H. Identification of a phospholipase C beta subtype in rat taste cells. Eur J Cell Biol 77: 253-261, 1998[ISI][Medline].

43.   Ruiz-Avila, L, McLaughlin SK, Wildman D, McKinnon PJ, Robichon A, Spickofsky N, and Margolskee RF. Coupling of bitter receptor to phosphodiesterase through transducin in taste receptor cells. Nature 376: 80-85, 1995[ISI][Medline].

44.   Seto, E, Hayashi Y, and Mori T. Patch clamp recording of the responses to three bitter stimuli in mouse taste cells. Cell Mol Biol (Noisy-le-grand) 45: 317-325, 1999.

45.   Spielman, AI. Gustducin and its role in taste. J Dent Res 77: 539-544, 1998[Abstract].

46.   Spielman, AI, and Brand JG. Collection of taste tissue from mammals. In: Experimental Cell Biology of Taste and Olfaction. Current Techniques and Protocols, edited by Spielman AI, and Brand JG.. Boca Raton, FL: CRC, 1995, p. 25-32.

47.   Spielman, AI, Brand JG, Nagai H, Huque T, and Whitney G. Generation of inositol phosphates in bitter taste transduction. Physiol Behav 56: 1149-1155, 1994[ISI][Medline].

48.   Spielman, AI, Huque T, Whitney G, and Brand JG. The diversity of bitter taste signal transduction. Soc Gen Physiol Ser 47: 307-324, 1992[Medline].

49.   Spielman, AI, Mody I, Brand JG, Whitney G, MacDonald JF, and Salter MW. A method for isolating and patch-clamping single mammalian taste receptor cells. Brain Res 503: 326-329, 1989[ISI][Medline].

50.   Spielman, AI, Nagai H, Rosenzweig S, Sunavala G, Nakagawa M, Amachi T, and Brand JG. IP3---a common second messenger for many bitter compounds (Abstract). Chem Senses 22: 192-193, 1997.

51.   Spielman, AI, Nagai H, Sunavala G, Dasso M, Breer H, Boekhoff I, Huque T, Whitney G, and Brand JG. Rapid kinetics of second messenger formation in bitter taste. Am J Physiol Cell Physiol 270: C926-C931, 1996[Abstract/Free Full Text].

52.   Stewart, CN, Thomsen MW, Woudsma KA, Brand JG, Sunavala G, Nagai H, and Spielman AI. Behavioral response of rats to benzyltriethylammonium chloride (BTAC) taste and associated inositol trisphosphate response in lingual tissue (Abstract). Chem Senses 21: 677, 1996.

53.   Sunavala, G, Dasso M, and Spielman AI. Time-course of bitter-induced levels of IP3 and cAMP in mouse tissue (Abstract). Chem Senses 20: 787, 1995.

54.   Tareilus, E, Boekhoff I, Spielman AI, and Breer H. Approaches for monitoring rapid kinetics of second messenger signaling. In: Experimental Cell Biology of Taste and Olfaction. Current Techniques and Protocols, edited by Spielman AI, and Brand JG.. Boca Raton, FL: CRC, 1995, p. 193-202.

55.   Tsunenari, T, Kurihashi T, and Kaneko A. Activation by bitter substances of a cationic channel in membrane patches excised from the bullfrog taste receptor cell. J Physiol (Lond) 519: 397-404, 1999[Abstract/Free Full Text].

56.   Whitney, G, Harder DB, Gannon KS, and Maggio JC. Congenic lines differing in ability to taste sucrose octaacetate. In: Chemical Senses: Genetics of Perception and Communication, edited by Wysocki CJ, and Kare MR.. New York: Marcel Dekker, 1991, vol. 3, p. 243-262.

57.   Williams, RL. Mammalian phosphinositide-specific phospholipase C. Biochim Biophys Acta 1441: 255-267, 1999[ISI][Medline].

58.   Wong, GT, Gannon KS, and Margolskee RF. Transduction of bitter and sweet taste by gustducin. Nature 381: 796-800, 1996[ISI][Medline].

59.   Yokomukai, Y, Cowart BJ, and Beauchamp GK. Individual differences in sensitivity to bitter-tasting substances. Chem Senses 18: 669-681, 1993[ISI].


Am J Physiol Cell Physiol 280(4):C742-C751